GlaxoSmithKline PLC (LSE:GSK) - Share price

Stock Report

GlaxoSmithKline PLC GSK

Directors' Share Dealings
 Transaction Holding 
Director/Date/TypeAmountPrice (GBX)Value (£) Amount% Additional Info
Ms. Emma N. Walmsley
09/06/2021 | Purchase
91,361.95123.00 1,190,5700.024 Partnership
Dr. Hal V Barron
07/06/2021 | D
1,19538.7546,306.00 671,3580.013 Dividend Reinvestment Plan(DRIP)
Dr. Hal V Barron
24/05/2021 | Purchase
2,39419.3446,288.00 670,1630.013 ADRs
Dr. Hal V Barron
20/05/2021 | D
13419.522,615.00 667,7690.013 Dividend Reinvestment Plan(DRIP)
Dr. Hal V Barron
20/05/2021 | D
5,10419.5299,605.00 667,6350.013 Dividend Reinvestment Plan(DRIP)
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.